Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Biodesix, Inc.

< Previous 1 2 3 4 Next >
Biodesix to Present at Canaccord Genuity’s 44th Annual Growth Conference
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Report Second Quarter 2024 Financial Results on August 7, 2024
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Named to Inc. Magazine’s 2024 “Best Workplaces”
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Participate in Two Investor Conferences in June
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Present New Data on the Nodify XL2® Test at ATS 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Participate in Two Upcoming Investor Conferences in November
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces Third Quarter 2023 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Participate in Two Upcoming Investor Conferences in September
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces Second Quarter 2023 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Report Second Quarter 2023 Financial Results on August 7, 2023
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces Publication of the ORACLE Clinical Utility Study with the Primary Endpoint Demonstrating that the Nodify XL2® Test Reduced Unnecessary Invasive Procedures on Benign Lung Nodules
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Awarded Advanced Diagnostic Laboratory Test Status for its Nodify CDT® Test by the Center for Medicare and Medicaid Services
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Completes Enrollment of INSIGHT Study Assessing Clinical Utility of the VeriStrat® Blood-Based Host Immune Classifier
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix Announces Three Abstracts to Be Presented at ASCO 2023 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
Biodesix to Participate in William Blair’s 43rd Annual Growth Stock Conference
From Biodesix, Inc.
Via Business Wire
Tickers BDSX
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.